Pleural Neoplasms
Recent clinical, regulatory, research and industry developments relating to this disease.
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- The Journal of clinical investigation1
Leading researchers8
- Adusumilli PS1
- Cherkassky L1
- Dimitrov DS1
- Feng Y1
- Jones DR1
- Morello A1
- Sadelain M1
- Villena-Vargas J1
Affiliations (unnormalised)3
- Center for Cell Engineering and1
- Laboratory of Experimental Immunology1
- Memorial Sloan Kettering Cancer Center1
Reference
Authoritative identity, definition & identifiers.
Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.